Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors
- PMID: 11062168
- DOI: 10.1093/carcin/21.11.2057
Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors
Abstract
p14(ARF) is a putative tumor suppressor gene thought to modify the levels of p53. CpG sites within the 5'-flanking region and exon 1beta of p14(ARF) are targets of aberrant methylation and transcriptional silencing in human colorectal cancer (CRC). Here we have developed methylation-specific polymerase chain reaction (MSPCR) methods to detect methylation of CpG sites in p14(ARF) in CRC cell lines and primary CRC tumors, and correlated p14(ARF) mRNA expression with methylation in CRC cell lines using competitive quantitative reverse transcription-polymerase chain reaction methods. Ten CRC cell lines were studied; three (DLD-1, HCT15 and SW48) showed extensive methylation and six (Colo320, SW480, HT29, Caco2, SW837 and WiDr) were unmethylated; the other cell line, LoVo, showed partial methylation that affected exon 1beta but not the immediate upstream CpG sites. p14(ARF) mRNA was expressed at extremely low levels in fully methylated cell lines and at 10(4)- to 10(5)-fold higher levels in unmethylated cell lines. p14(ARF) expression in the partially methylated LoVo cell line was intermediate. Treatment of LoVo cells with 2 microM 5-aza-2'-deoxycytidine for 72 h was associated with marked (100-fold) induction of mRNA levels. Of 119 primary CRCs, 18% contained p14(ARF) methylation, although partial methylation was the most common pattern observed (in 67% of methylated tumors). Methylation of p14(ARF) was often accompanied by p16(INK4a) methylation; however, 50% of p14(ARF) methylated tumors contained unmethylated p16(INK4a). Methylation at p14(ARF) was associated with female gender, greater age, proximal anatomic location and poor differentiation, but not stage at diagnosis. A two-step MSPCR method for assaying p14(ARF) methylation in human tumors is described.
Similar articles
-
INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.Oncogene. 2001 Oct 25;20(48):7104-9. doi: 10.1038/sj.onc.1204902. Oncogene. 2001. PMID: 11704835
-
Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.Mol Cancer Ther. 2009 Apr;8(4):779-85. doi: 10.1158/1535-7163.MCT-08-0926. Mol Cancer Ther. 2009. PMID: 19372550
-
Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.Cancer Res. 2000 Jan 1;60(1):129-33. Cancer Res. 2000. PMID: 10646864
-
Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.Chin Med J (Engl). 2003 Jul;116(7):1083-7. Chin Med J (Engl). 2003. PMID: 12890389
-
Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.Cancer. 2008 Apr 15;112(8):1699-707. doi: 10.1002/cncr.23335. Cancer. 2008. PMID: 18327804
Cited by
-
The effects of thymidylate synthase 3'UTR genotype on methylation of tumor-specific genes promoter in 22 colorectal cancer patients from southern Iran.Mol Biol Res Commun. 2024;13(2):89-102. doi: 10.22099/mbrc.2023.48009.1850. Mol Biol Res Commun. 2024. PMID: 38504782 Free PMC article.
-
Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis.PLoS One. 2016 Mar 21;11(3):e0152050. doi: 10.1371/journal.pone.0152050. eCollection 2016. PLoS One. 2016. PMID: 26999279 Free PMC article.
-
p14(ARF) methylation is a common event in the pathogenesis and progression of myxoid and pleomorphic liposarcoma.Med Oncol. 2013;30(3):682. doi: 10.1007/s12032-013-0682-9. Epub 2013 Aug 6. Med Oncol. 2013. PMID: 23918242
-
Quantification of epigenetic biomarkers: an evaluation of established and emerging methods for DNA methylation analysis.BMC Genomics. 2014 Dec 23;15(1):1174. doi: 10.1186/1471-2164-15-1174. BMC Genomics. 2014. PMID: 25539843 Free PMC article.
-
Hypermethylation of the 5' CpG island of the p14ARF flanking exon 1β in human colorectal cancer displaying a restricted pattern of p53 overexpression concomitant with increased MDM2 expression.Clin Epigenetics. 2012 Jun 15;4(1):9. doi: 10.1186/1868-7083-4-9. Clin Epigenetics. 2012. Retraction in: Clin Epigenetics. 2023 May 17;15(1):88. doi: 10.1186/s13148-023-01504-x. PMID: 22703554 Free PMC article. Retracted.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous